Home » International News » 2013 » July » July 2, 2013

Taro Annual Report For Fiscal Year Ended March 31, 2013 on Form 20-F Available

July 2, 2013 - Hawthorne, New York, United States

Taro Pharmaceutical Industries Ltd. (NYSE: TARO, “Taro”) announced that its Annual Report for fiscal year ended March 31, 2013 on Form 20-F, filed with the Securities and Exchange Commission (the “SEC”) today, is available within the Investor Relations section of Taro’s website at Hard copies of the report may be ordered free of charge by sending requests to Taro Pharmaceuticals U.S.A., Inc., Three Skyline Drive, Hawthorne, NY 10532, attention: William J. Coote or via email to

Additionally, the report may be accessed on the SEC’s website at

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit Taro’s website at

CONTACTS : Taro Pharmaceutical Industries Ltd. William J. Coote, 914-345-9001 VP, Treasurer

Source: Business Wire India


Comment on this story